The dynamic response of squared conduction velocity, 92, to repetitive stimulation in canine Purkinje fibers with quinidine was studied using a double-microelectrode technique. With stimulation, a frequency-dependent monoexponential increase in conduction delay (CD) and a decline in 92 were observed. The exponential rates and changes in steady-state CD and 92 were frequency-and concentration-dependent. The overall drug uptake rates describing blockade and the interpulse recovery interval were linearly related and steady-state values of 92 were linearly related to an exponential function of the stimulus intervals. Based on first-order binding, the frequency-and concentration-dependent properties of quinidine were characterized by the apparent binding and unbinding rates of 14.2±5.7 X 106 mol-' s-and 63±12 s-' for activated and 14.8±1.0 X 102 mol' . *s-and 0.16±0.03 so' for resting states. The recovery time constant extracted from the pulse train interpulse interval was 5.8±1.5 s compared with 5.1±0.6 s determined from a posttrain test pulse protocol. This study demonstrates that the kinetics ofdrug action can be derived from measures of impulse propagation. This provides a basis for characterizing frequency-dependent properties of antiarrhythmic agents in vivo and suggests the plausibility of a quantitative assessment of drug binding and recovery rates in man.
Introduction
The fundamental role of the inward sodium current (INa)' as the driving force behind impulse propagation is indicated by the conduction modification accompanying alterations in sodium channel conductance. Declining conduction velocity (0) or other measures of conduction delay (CD) have been shown to accompany both the decline in Vma produced by a reduction in extracellular sodium concentration (1) and drug-induced sodium channel blockade (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) tive observations, the precise mathematical relationship between measures of channel conductance and impulse propagation has been more difficult to specify.
Investigations to explore this relationship have nevertheless been made on both theoretical and experimental levels. Donati and Kunav (13) in studying 0 in unmyelinated axons have shown that in the absence of contaminating currents, the squared conduction velocity, 92, is directly proportional to the product of available sodium channel conductance and a function dependent on the threshold of excitability. Walton and Fozzard (14) demonstrated experimentally a nearly linear relationship between peak inward ionic current normalized by the capacitance that is filled during the upstroke of the action potential and 0. The cable equation adapted for the physiologic setting by Hodgkin and Rushton (I5) also predicts a theoretical linear relationship between early net membrane currents and 02. In a study showing quinidine and procainamide-induced use-dependent modification off2 in guinea pig papillary muscle, Buchanan and co-workers (1 1) provided experimental verification ofa 1:1 relationship between steady-state Vma. and 92 over a wide range of drug concentrations and stimulus frequencies. Nevertheless, kinetic studies fully characterizing the relationship between these parameters under transient or dynamic conditions have not been available.
Antiarrhythmic drug modification of INa has been extensively characterized. Johnson and McKinnon (16) demonstrated that the degree ofquinidine-induced depression of Vm,, in guinea pig ventricular muscle was a function ofthe stimulation frequency. This observation has subsequently been confirmed in both nerve and cardiac tissue (17) (18) (19) (20) (21) (22) , and has led to the term use dependence (19) to describe the accumulation of channel blockade occurring with repetitive stimulation. Although other studies have demonstrated analogous use-dependent CD in animals (6, 7, 11, 23) and in humans (8) (9) (10) 24) , complete parallel kinetic studies from measures ofconduction have not been available.
We have previously shown that the drug-induced reduction of peak INa, which follows an exponential time course, allows estimation of apparent binding and unbinding rates (25) . Assuming a near linear relationship between sodium conductance and 02, it follows that in the presence of drug, small transient changes in 02 occurring over a pulse train should likewise follow an exponential time course. This pattern of blockade accumulation should also allow the determination of apparent binding and unbinding rate constants from measures of propagation. Because description of the kinetic and steady-state effects of antiarrhythmic agents in humans remains dependent on demonstrable changes in CD, this capability could be useful in understanding further the mechanism of action and quantifying the effects of antiarrhythmic agents in man.
With this focus on clarifying the dynamic modification of impulse propagation by antiarrhythmic agents and its relationship to channel activity, we sought to (a) develop a kinetic description of the onset of and recovery from use-dependent channel blockade manifest by declining 02 and CD as measures of conduction in a simple propagating system; and (b) determine whether the kinetics of blockade recovery can be extracted from the recovery interval between two consecutive pulses of a drive train.
We found that the frequency and concentration-dependent properties of quinidine can be characterized by a set of frequency-independent rate constants derived from CD and 02, suggesting that under appropriate conditions, measures of conduction might be used to more completely characterize drug effects in humans. Preliminary reports of this study have recently appeared in abstract form (26, 27) .
Methods
Experiments were performed on unbranched Purkinje fibers obtained from 15-25-kg mongrel dogs after 30 mg/kg pentobarbital anesthesia i.v. Fiber dissection was completed in high potassium cardioplegia solution after rapid excision ofthe heart. Fibers > 1 cm long were fixed in a lucite chamber and superfused for 1 h with control Tyrode's solution containing (in millimolar: 120, NaCl; 22, HCO3; 5, dextrose; 0.5, MgCl2; 0.5, NaH2PO4; 2.5, CaCl2; and 5.4, KCL. Temperature was maintained at 36.5±0.50C using a constant temperature circulator and pH at 7.40±0.05 by equilibration with a gas mixture of95% 02 and 5% CO2. The superfusate flow rate was maintained at 8-10 ml/min.
The transmembrane potential (Vm) was recorded from two microelectrodes positioned in the middle and distal end ofthe Purkinje fiber. The interelectrode distance, determined using a calibrated eyepiece, ranged between 3.8 and 9.2 mm (mean = 5.5±1.5 mm). Microelectrodes beveled to a resistance of 8-16 mQ were filled with 3 M KCI and coupled via a Ag/AgCl wire to a high impedance microprobe system (WPI 700; World Precision Instruments, New Haven, CT). Vm and a 100-ms time marker were simultaneously displayed on an oscilloscope (model 565; Tektronix, Inc., Beaverton, OR) and photographed on 35-mm film using a kymographic camera (Model C4; Grass Instruments, Quincy, MA). Action potential duration (APD-90) and Vm were measured directly from the film. The signal from each microelectrode was also differentiated electronically using an analogue differentiator and sample-hold peak detection circuit, modified from Hon- deghem and Cotner (28). The derivative was filtered and held for 90 ms to allow recording on a strip chart recorder (model 2200, Gould Inc., Cleveland, OH) at a paper speed of 5 mm/s (Fig. 1 ). The recording system was linear over a range from 200-1,000 V/s. An interval timing circuit was used to determine the interelectrode conduction time from the peak VJa at each microelectrode. The Vmax from the proximal and distal microelectrodes and the conduction time were digitized from the strip chart records for subsequent data analysis. 02 was determined from the interelectrode distance and corresponding conduction time. Although Vmax may be an imperfect reflection of sodium conductance, the application ofthe microelectrode technique facilitated the study of conduction and the comparison of use-dependent drug blockade manifest by incremental CD, 02, and Vma, under physiologic temperatures, which would have been impossible under voltage clamp. Stimulation protocol. The Purkinje fiber was stimulated near its end using a pair of silver wires positioned at a distance of 4-6 mm proximal to the first electrode, using 1.0 ms constant current pulses at a strength of 1.5-3 times diastolic threshold. Drug uptake, as indicated by incremental CD and 02, was assessed using 20-s pulse trains with interstimulus intervals (ISIs) within the train of 1.5, 1.0, 0.9, 0.8, 0.7, 0.6, 0.5, and 0.4 s. 20 s was allowed between each pulse train to permit complete recovery from blockade. After control observations, the fibers were superfused with 4 ,g/ml quinidine gluconate (7.6 X 10-6 M) or 8 ,g/ml (1.52 X 10' M) with at least 1 h allowed for equilibra- Significant use-dependent channel blockade was manifest by incremental CD occurring over the course of the pulse train as shown in Fig. 2 for ISIs of 1.5, 0.8, and 0.5 s. A corresponding decline in 02 over the pulse train was likewise observed. The respective prolongation ofCD as well as decline in 0 and 02 proceeded until steady state was achieved, with the greatest steady-state blockade observed at the shortest ISI. Steady-state values for each indicator of drug-channel interaction with 4 or 8 ,g/ml quinidine at ISIs of 1.0 and 0.5 s are shown in Table I .
Conduction time prolonged 33% at the longer and 55% at the shorter ISI. 0 declined 24 and 35%, respectively, at the same ISIs, whereas the change in 02 (37 and 54%, respectively) paralleled that observed with CD and Vm.. With 8 gg/ml quinidine, a greater prolongation of conduction time was observed with a 41% increase over control at the 1.0-s ISI and 65% increase at the 0.5-s ISI, 10% greater than observed at the 4 ,gg/ml concentration. 02 likewise underwent a 50% decline at the longer and 63% decline at the 0.5-s ISI.
The time course of use-dependent CD or declining 02 could be adequately fit by an exponential expression, yielding an overall drug uptake rate, X*, for each ISI as also shown in Fig.  2 . The greatest apparent drug uptake per pulse was observed with the slowest pacing rates. The X*'s derived from each ofthe three measures of conduction modification by quinidine were equivalent.
The predicted linear relationship between X* derived from CD and 02 and the accompanying interpulse recovery interval (tr = ISI -APD) was linear as shown for 02 in Fig. 3 . A similar linear relationship was observed when X* was derived from Vmax. The activated state uptake rate constant, Xa, at 4 gg/ml derived from the y-intercept of this relationship averaged 112±5 s-' using information derived from CD and was 149±12 s51 from 02. In fibers superfused with 8 ug/ml quinidine, Xa was significantly larger than those at the lower concentration, as shown in Table II : 187±35 s-' from CD (P < 0.001), and 252±54 s51 from 02 (P < 0.005). The time constants of acquisition of blockade, Ta, where Ta = 1/Xa = (kaD + la)-I was therefore greater at the lower drug concentration of 4 ,g/ml than at 8 ,g/ml (Table II) (Table III) . Activated and resting equilibrium blockade. The steadystate term, y, as derived in Eq. 10 (see Appendix) was estimated for each preparation using A* and Xr. The activated or excited state equilibrium blockade, a., was determined from the y-intercept of the regression of steady-state blockade for each ISI with the corresponding y, as shown in Fig. 4 Table II . Significantly higher fractional equilibrium blockade with 8 pg/ml was noted in each ofthe measure ofimpulse propagation. In addition, a,, obtained from 02 was almost two times greater than that observed than derived from 0.
The resting equilibrium blockade or tonic blockade, r0,, could also be quantified from the slope of the relationship shown in Fig. 4 without the bias created by drug uptake occurring during a traditional test pulse. As seen in Table III Apparent rate constants. The calculated forward and reverse apparent drug binding rate constants are shown in Table  IV . Because the estimates offorward and reverse rate constants were independent of drug concentration, the results given in This trend reached significance only when using incremental CD but not 02 as the indicator of use-dependent drug effect.
Discussion
In this study, we have demonstrated that quinidine induces a frequency-dependent decline in 02 and CD over a pulse train This study also demonstrates that the kinetics of recovery can be comparably described using CD and 02 as the measure of channel blockade. Excellent agreement was noted between those rs derived from CD, 02, as well as Vmax. These findings complement those of Nattel (12) , who in studies of canine Purkinje fibers exposed to 18-74 ,M lidocaine also observed a monoexponential recovery process and agreement between recovery time constants derived from both recovering .ma. and conduction delay. At higher concentrations (147 ,1M) general agreement between rrs derived from conduction delay and Vmax was also observed, although the recovery process deviated from a perfectly linear relationship at the shortest recovery intervals. This suggested a nonexponential recovery phase when described by changes in conduction delay but not Vmax
We saw no consistent comparable deviation from a truly monoexponential recovery process from incremental conduction delay with either 4 or 8 ,gg/ml quinidine, however.
The time course of recovery from drug-channel blockade, extracted from drug uptake pulse train studies, was also found to be in reasonable experimental agreement with those determined applying traditional methods. In both cases the kinetics of recovery were independent ofthe initial level ofblockade as previously shown (29, 30, 51). Both methods provided TrS of 4-6 s, which agree closely with the 4-1O-s values previously reported (17, 29, 51).
The small difference in recovery rate constants may be related to slightly less negative membrane potentials at the take off point of the action potential producing expected prolongation of recovery time (29, 40, 41, 53, 56) . This might be related to an accumulation ofextracellular K+ with pacing (55, 57-6 1) or the effect ofincomplete recovery from the preceding action potential. Both effects might be expected to yield greater X*s, particularly at faster pacing rates, and thus flatten the slope of the relationship between X* and Tr as shown in Fig. 3 . Nevertheless, this difference is insignificant and the agreement between both methods provides strong support for the assumptions made in the model.
From kr and Ir, equilibrium blockade at resting Vm or tonic blockade can also be predicted without the first pulse bias found using traditional techniques. Such bias might develop because of drug uptake in the test pulse or arise because of any increase in inactivated channels accompanying a small decline in resting Vm occurring during the prolonged diastolic interval. The guarded receptor approach, however, allows for tonic blockade determination from pulse train stimulation independent of these effects. The 3% tonic blockade observed in these conduction studies is consistent with earlier reports (22, 54), and also argues against any appreciable contribution of diastolic changes in resting Vm to total blockade.
Limitations of the study. 
Appendix Additional analytical methods
The forward and reverse rate constants for quinidine binding were determined using the guarded receptor formalism (33-39). With this approach, channels are viewed as voltage-dependent mixtures of accessible or inaccessible conformations. During stimulation or switching to activated potentials, the equilibrium shifts to favor a channel mixture in which accessible or unguarded channel conformations predominate, allowing drug access and binding to the receptor to occur. Upon return to resting potentials, the equilibrium shifts such that inaccessible or guarded channel conformations dominate the mixture.
This approach predicts that the time course of blockade during a train of pulses can be described by a piecewise exponential process. For a two-mixture process, this produces an alternating sequence of two exponentials, where the first describes drug uptake occurring at activated potentials when accessible channels predominate (34). The fraction of blocked channels at the end of accessible phase, ao, can be written as: ao = roeXa + a..(l -e-Xa) (1) terms oftime course. A description ofthe kinetics ofrecovering should therefore be available from this interstimulus recovery interval. Blockade associated with the nth pulse of a train can be described recursively in terms ofblockade acquired during the preceding pulse by the relationship: an+ = ane-(\+Xt'r) + r(l e-r)e + a (l - (3) This defines the overall drug uptake rate, X*, as the weighted sum ofthe two state-dependent uptake rates which predicts a linear relationship between X*, determined from an exponential fit to declining 1/max or incremental conduction delay at any given interstimulus interval and tr, the recovery interval between pulses. For open-channel blockade as expected with quinidine (29, 31-32), ta is presumed to be the mean channel open time, which is assumed to be constant during pulse train stimulation (66). We (6) Here ka is the forward and la is the reverse activated state rate constant.
With repetitive stimulation, steady-state is reached, which can be described in terms ofthe recursive relationship for the fraction ofblock immediately before depolarization: a. (I -ex)eXr + r (I -e-1 -e-\ (7) where a,, is the activated state and rOO is the resting state equilibrium.
The fraction of block immediately after depolarization at steady state can be comparably derived. Here a,, and reO are respectively given by: icaD = kaD + 'a krD -krD + 'r (8) (9) Eq. 7 can be rewritten in terms of the constant y and 1 -y, where where ro is the amount of blockade before that activation and the exponential expression e-Xaa describes drug uptake between those two points. Here ta is equal to the interval of time the binding site is accessible and Xa equals the activated drug uptake rate constant I/Ta =kaD + la.
Similarly, the second exponential describes drug recovery occurring during the interstimulus interval between two pulses of a train. Here, r, = a0ex rt + r,(l-eXAtr) (2) where r1 reflects the amount ofblockade after the recovery interval and a0 is the fraction of blocked channels prior to recovery, along with the exponential e-Art describing the time course of recovery between those two points. tr is the recovery time between pulses, and Xr is the recovery rate constant or I /rr = krD + Ir. An additional prediction of the model is that recovery occurring between two pulses of a train and that occurring after cessation of the drive train stimulation are equivalent in 
